Changeflow GovPing Drug Safety Safety alert for DermaGenius 3.0 reagent
Priority review Notice Amended Final

Safety alert for DermaGenius 3.0 reagent

Favicon for ansm.sante.fr ANSM Drug & Device Safety Alerts
Published March 13th, 2026
Detected March 13th, 2026
Email

Summary

The French National Agency for Medicines and Health Products Safety (ANSM) has issued a safety alert regarding the DermaGenius 3.0 Complete Multiplex real-time PCR reagent. This alert, registered under number R2607183, informs medical biology analysis laboratories of a security action implemented by PathoNostics.

What changed

The ANSM has issued a safety alert (Information n° R2607183) concerning the DermaGenius 3.0 Complete Multiplex real-time PCR reagent, following a security action initiated by the manufacturer, PathoNostics. The alert is directed at medical biology analysis laboratories, and users have been notified via a letter from the company. The ANSM is not the direct issuer of the security action but is registering it and providing information to affected parties.

Laboratories using this reagent should review the security action details provided by PathoNostics, as outlined in the letter dated March 13, 2026. For specific questions or to understand the implications of this security action, laboratories should contact PathoNostics directly. The ANSM's role here is informational, ensuring awareness within the regulated community.

What to do next

  1. Review the security action letter from PathoNostics dated 2026-03-13.
  2. Contact PathoNostics directly for any questions regarding the security action.

Source document (simplified)

A+ A-

Information n° R2607183 destinée aux laboratoires d'analyses de biologie médicale L'ANSM a été informée de la mise en œuvre d’une action de sécurité effectuée par la société PathoNostics.
Les utilisateurs concernés ont reçu le courrier ci-joint.

Cette action de sécurité est enregistrée à l’ANSM sous le n° R2607183.
Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Consultez le courrier de la société PathoNostics (13/03/2026)

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
Various
Published
March 13th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Healthcare providers
Geographic scope
INT

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Medical Devices Product Safety

Get Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.

Free. Unsubscribe anytime.